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ABSTRACT 
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AIMS AND OBJECTIVES:  To evaluate the probable association of HPV infection 
with high risk genotypes 16 and 18 in patients with squamous cell oesophageal 
carcinoma. 
 
BACKGROUND: Oesophageal carcinomas are the eighth most common cancer 
worldwide and sixth most common cause of death worldwide from cancer. The 
etiology is unknown and many factors are involved in the carcinogenesis. The 
association of high risk HPV types16 and 18 in squamous cell carcinoma of the 
oesophagus is variable and still controversial in literature. There is limited data from 
India and no data available from South India. The objective of our study was to 
determine any association of HPV high risk types 16 and 18 in patient with 
squamous cell oesophageal cancer. 
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METHODS: This was a prospective observational case control study done over 2 
years.  The total number of case participants (Group A ) was 45 and control 
participants (Group B) were 38.  The endoscopy biopsy tissue was collected from 
both the tumour and adjacent normal healthy mucosa in patients with squamous cell 
carcinoma of oesophagus. From the control participants biopsy was collected from 
the normal oesophageal mucosa. The collected samples were coded and sent for 
analysis for the presence of high risk HPV DNA types 16 and 18 by PCR. 
  
 
 
 
RESULTS:  In this study high risk HPV DNA types 16 and 18 were not present in 
patients with squamous cell carcinoma of oesophagus.   There was also absence of 
HPV in the control participants. However there is need for a larger study to 
investigate the probable association of HPV in the etiology of squamous cell 
carcinoma of oesophagus. 
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                         INTRODUCTION 
 
Oesophageal malignancy is the eighth most common cancer worldwide and also 
sixth most common cause of death worldwide from cancer. (1)The long-term survival 
rate from the oesophageal cancer is about 19%, which is due to the fact that patients 
present at advanced stage. (2) (3) 
 It is also known that the incidence of oesophageal malignancy shows wide 
variations across the different geographical regions of the world. (4) 
Oesophageal malignancy is common in Indian population. (5)    A variation in 
incidence rate is also seen in different parts of our country. (5) It is an important 
leading site of cancer in both males and females. The average age adjusted 
incidence rate for cancers of oesophagus in India is 8 per 100,000 population. (1) 
The precise etiologic factor for squamous cell carcinoma (SCC) of the oesophagus is 
not known. (8) 
However, it is important to understand the various agents causing cancer to 
understand its precise mechanism of molecular pathogenesis, identify biomarkers for 
early diagnosis and better management of this malignancy. (5) 
Carcinogenesis being a multistep process, a number of various biological and 
environmental agents is involved. (6) 
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Infection with oncogenic HPV types may be an integral step in this multilevel process 
that leads to oesophageal carcinoma. (6) 
The first observation of involvement of Human Papilloma virus (HPV) in the aetiology 
of squamous cell carcinoma of the oesophagus dates back to 1982. (7) Following 
this, there is wide variation in the literature regarding HPV detection in patients with 
SCC oesophagus. . 
The available evidence in the literature suggests that the similar mechanisms of 
carcinogenesis occur in cervical cancer and SCC of the oesophagus.  The HPV E6 
and E7 oncogenes interfere with normal cell cycle regulation resulting in abnormal 
proliferation leading to malignancy. (8)(9) 
The prevalence of HPV in cases of SCC oesophagus is highly variable across 
various geographical regions worldwide, being significantly higher in high-incidence 
regions as compared to low-incidence regions. (10)(11)(12)(13) 
This concept was recently substantiated by a large meta-analysis of the data from 
1954 – 2012 recently elaborated the concept that oesophageal squamous cell 
carcinoma might have a different aetiology in low and high incidence geographic 
regions. (14) The HPV plays a far more important role in the high incidence regions 
of oesophageal malignancy. (14)  
It is possible that different etiologic factors may exist in high risk as opposed to low 
risk geographical areas.  This can explain the difference in detection rates of HPV in 
oesophageal malignancy from different geographical areas worldwide.  
 
5 
 
Although India also has high prevalence of oesophageal cancer in the sub continent, 
the incidence is not as high compared to mainland China, Iran and Traneki region of 
South Africa, where the prevalence rate has been quoted to about 250 per 100,000 
populations. (71). There is very limited data from India which would identify any such 
association of high risk HPV types with squamous cell carcinoma of the oesophagus. 
India being a low prevalence area for oesophageal carcinoma, the role of HPV virus 
in the aetiology of this cancer is doubtful.   
Secondly, there exists variation in the prevalence of this malignancy in different 
geographic areas within the country. (This malignancy is common in the Southern 
states, North eastern states and in the Valley of Kashmir).  
 This study was designed to assess the prevalence of HPV infection (high risk 
genotypes 16 and 18) in patients with biopsy proven squamous cell oesophageal 
carcinoma.  
The study includes patients from different geographic areas within India to look for 
any possible association in any of the geographic high prevalence areas in India. 
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AIM 
       
         To evaluate  the probable association of HPV infection with 
genotypes 16 and 18 in patients with squamous cell oesophageal 
carcinoma in Indian patients. 
 
 
 
 
OBJECTIVE 
 
To assess the detection rate of high risk HPV types 16 and 18 in 
patient with squamous cell oesophageal carcinoma. 
 
 
 
 
 
 
7 
 
LITERATURE REVIEW 
 
Oesophageal carcinomas are the eighth most common cancer worldwide, with about 
481, 000 new cases (3.8% of the total) estimated in 2008, and sixth most common 
cause of death from cancer worldwide from cancer with 406,000 deaths (5.4% of the 
total). (1) This figure includes both the two major types of oesophageal malignancy 
i.e. squamous cell carcinoma (SCC) and adenocarcinoma. (1)  
Of the two common types, the squamous cell type of oesophageal malignancy  is the 
most common type worldwide.(14)(72)  It is also the fifth most common cancer in the 
developing countries.(1) More than 80% of the cases and deaths due to 
oesophageal carcinoma occur in developing countries.(1)  
The long-term survival rate of oesophageal malignancy is 19 %,( 2) which are largely 
due to the fact that these cancers are detected in an advanced stage. (15) Thus they 
present a therapeutic challenge to the clinicians. There is reported little difference in 
outcome between the two histologic types of carcinoma. (16)  
The oesophageal cancer male: female ratio is 3 – 4: 1 in low risk countries but in 
high risk countries or region there exist no gender differences. 
The squamous cell carcinogenesis of the oesophagus is complex multistep process 
and it is hypothesised to have multifactor aetiology and no single agent is identified 
to cause malignancy. In the past two decades HPV has gained the interest to be the 
most likely infectious viral agent leading to oesophageal cancer. 
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EPIDEMIOLOGY -  
The oesophageal cancer incidence rate varies internationally by nearly 16-fold 
across the different regions worldwide. The regions reported with highest incidence 
are Southern and Eastern Africa with regions of Eastern Asia, and regions with 
lowest of incidence are Western and Middle Africa and Central America. (17) 
The area stretching across the Northern Iran through the central Asian republics to 
North-Central China which is often referred as “oesophageal cancer belt” .This is the 
region with highest risk for oesophageal carcinoma. The 90 percent of the cancer 
cases here are of squamous cell type. (18)  
In such endemic areas the incidence is as high as 250 cases per 100,000 persons. 
(19) In contrast, the combined incidence of squamous cell and adenocarcinoma of 
the oesophagus in the United States is 4 cases per 100,000 persons. The reasons 
for such a vast geographic discrepancy are unknown.  
It is suggested that it is linked to the local arid climate and alkaline soil, as well as 
ingestion of nitrosamines and inversely to the consumption of riboflavin, nicotinic 
acid, magnesium and zinc. The highest mortality rate among both male and female 
occurs in developing countries across Eastern and Southern Africa, and in Eastern 
Asia.(1) 
In North America and Western Europe in contrast, alcohol and tobacco use are the 
major risk factors for causing squamous cell carcinoma and account for 80 – 90% of 
cases. (20)(21) A study describes the relative risk of oesophageal cancer by the 
amount of alcohol and tobacco consumed as of 155: 1 when consuming > 30gm per 
day of tobacco along with 121gm of alcohol. (22) 
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CHANGE IN TREND OF OESOPHAGEAL CANCER IN WEST 
In United States, there is report of dramatic rise in incidence of adenocarcinoma of 
the oesophagus. In 1987, adenocarcinoma was reported in 34% and 12% of 
oesophageal cancers in Caucasian men and women with 3% and 1% for African 
American men and women, respectively. In the last 20 years there has been an 
increase in incidence of adenocarcinoma at a rate of 5% to 10 % per year.(23)(24)  
The reasons for such changes in trend is not well known but it has been 
hypothesised  that it is due to increase in risk factors  as overweight and obesity in 
the country’s general population. The trend in India has not shown any similar 
changes. The squamous cell carcinoma of the oesophagus is still the most common 
histological type of oesophageal carcinoma in our populations. 
 
THE INDIAN SCENARIO 
In India the cancer of oesophagus is one of the most common malignancies.(25) The 
incidence of the disease varies across the regions in different parts of the country .It 
is an important leading site of cancer in both males and females.(1)   
 
Of the two most common histological types, squamous cell carcinoma is the more 
common (90%), as compared with the adenocarcinoma of oesophagus. (26) There is 
no change in trend of the histologic types for the oesophageal cancer as 
documented in the US population. (26)  
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The Cancer of the oesophagus is third leading sites of cancer in Mumbai, Chennai 
and Bangalore registry, fourth in Bhopal and eighth in Delhi registry. (25) 
Average age adjusted incidence rate for cancers of oesophagus is 8 per 100,000 
populations. (1) 
The estimated mortality for Oesophageal carcinoma for the year 2008 among men in 
India was 6 per 1, 00,000 population and for women was 4.2 per 1, 00,000 
population. (1) 
Periodic variation in incidence rate of oesophageal cancer in India for women (age - 
standardised rate (W) per 100,000 women) is as shown (1) in Figure 1 
Figure 1 Variation in incidence rate of oesophageal cancer in Women
 
              (Adapted from GLOBOCAN 2008 (IARC (1) 
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 Periodic variation in incidence rate of oesophageal cancer in India for men (age-
standardised rate (W) per 100,000 men) is as shown: (1) Figure 2  
 
 
Figure 2 Variation in incidence rate of oesophageal cancer in Women 
 
 
 
 
 
                   (Adapted from GLOBOCAN 2008 (IARC)) (1) 
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THE OESOPHAGUS 
 
The oesophagus is a 25 cm long thin, muscular tube connecting the pharynx to the 
stomach. It extends from the lower border of the cricoid cartilage (at the level of the 
sixth cervical vertebra) to the cardiac orifice of the stomach at the side of the body of 
the 11th thoracic vertebra. (27) 
The oesophageal mucosa is lined over most of its length from cricopharyngeus 
muscle at the level of cricoid cartilage superiorly to the gastroesophageal junction 
inferiorly with stratified keratinized squamous epithelium.  
This epithelium gives rise to the squamous cell carcinoma, the most common 
neoplasm of the oesophagus. These cancers thus most often occur in the cervical 
and in the upper and middle thoracic oesophagus.  
The distal 2 to 3 cm of the oesophagus and the cardia are lined by columnar 
epithelium, in which adenocarcinoma may occur. (28) 
The oesophagus is divided into 3 parts. (Figure 3) They are -  
(1) The cervical part which extend from cricopharyngeus to the suprasternal notch. 
(2) The thoracic part which extends from suprasternal notch to the diaphragm. 
(3) The abdominal part extends from diaphragm to cardia of stomach. 
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Figure 3:         Different parts of Oesophagus  
 
(Figure 3 adapted from Kim T J et al. Radiographics 2009; 29:403-421) 
LYMPHATIC DRAINAGE 
The lymphatic system of oesophagus offers little barrier to the spread of malignancy 
as they are highly interconnected. Hence, the oesophageal tumour spreads early via 
lymphatics and has nodal deposits away from the primary lesion. This causes the 
presence of “skip areas” in between the lesions seen in oesophageal malignancy. 
(30) 
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The oesophagus has an extensive, longitudinally continuous, submucosal lymphatic 
system. The oesophagus has 2 types of lymphatic vessels which are (as depicted in 
figure 4) 
A plexus of large lymphatic vessels is present in the mucous membrane which is 
continuous above with the mucosal lymphatic vessels of pharynx and below with 
mucosal lymphatic vessels of gastric mucosa.  
The second plexus of finer vessels situated in the muscular coat. Efferent vessels 
from the cervical part drain into the deep cervical nodes. Lymphatics from the 
thoracic region drains in the posterior mediastinal nodes and lymphatic from the 
abdominal part   drains in to the left gastric nodes. Lymphatics can also drain directly 
in to the thoracic duct. (27) (28) 
Figure 4 –           Lymphatic system of Oesophagus 
 
 (Figure 4 Adapted from Rice T: Superficial oesophageal carcinoma: is there a need 
for three-field lymphadenectomy? Lancet 354:793, 1999) (29) 
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                                      ETIOLOGIC FACTORS 
 
The squamous cell carcinogenesis of the oesophagus is complex multistep process 
and it is hypothesised to have multifactor aetiology and no single agent is identified 
to cause malignancy.  
The following are the probable aetiologies’ for the squamous carcinoma of the 
oesophagus- 
(a) Hereditary 
 In regions with high incidence of oesophageal squamous cell carcinoma from 
China there are reports of familial aggregation. (31) Familial clustering was also 
reported from Sweden. (32)(33) But the role of hereditary factors in the 
pathogenesis of oesophageal cancer remains uncertain. 
 
(b) Geographic variations - 
The regions of high incidence of oesophageal cancer are found in Southern and 
Eastern Africa with Eastern Asia and regions with low incidence are Central 
America with Western and Middle Africa. (1) 
 
(c) Smoking and alcohol 
Smoking and drinking regular alcohol are important  risk factors for malignancies. 
High risk of oesophageal squamous cell carcinoma is associated with cigar and 
pipe smoking. Tobacco and alcohol together may increase the risk of 
carcinogenesis. (34)(35) 
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 (d)  Dietary factors    
Several dietary ingredients are associated  with oesophageal squamous cell 
carcinoma such as consuming N-nitroso compounds, chewing of areca nuts or 
betel quid, drinking hot tea or eating red meat.(36)(37) 
 
 Low selenium levels also increases the risk of oesophageal cancer. (38)  Zinc 
deficiency may enhance the carcinogenic actions of nitrosamines. (39) 
 
Drinking hot beverages as hot tea can increase the risk of oesophageal 
malignancy. A case control study from northern Iran shows a very significant 
association of drinking very hot tea and risk of squamous cell carcinoma of 
oesophagus. (40) 
 
(d) Underlying oesophageal disease  
The presence of pre-existing oesophageal conditions such as achalasia and 
corrosive strictures may increase the risk of oesophageal malignancy. (41) (42) 
 
(e) Prior gastrectomy 
 Patients  who had partial gastrectomy in past are at increased risk of developing 
oesophageal squamous cell cancer.  (43) 
 
(f) Atrophic gastritis 
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Atrophic gastritis is associated with two times increased risk of developing 
oesophageal cancer. (44) 
 
(g) Tylosis 
It is a rare autosomal dominant disease  with hyperkeratosis of  palms of  hands 
and soles of the feet. It is associated with a high rate of oesophageal cancer..(45) 
 
(h) Upper aerodigestive tract cancer  
Possible association is seen between current or past history of SCC of head and 
neck with synchronous or metachronous squamous cell carcinoma of the 
oesophagus. (47)(48) 
 
(i) Bisphosphonates 
Use of oral Bisphosphonates is reported to cause oesophageal malignancy in 
post-marketing surveillance. (46) 
 
(j) Human Papilloma Virus  
There is a huge variation (0 to 100 percent) in the prevalence of HPV associated 
with oesophageal malignancy in literature. HPV role is still debatable. 
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NATURAL HISTORY AND PATTERN OF SPREAD OF SQUAMOUS 
CELL CARCINOMA OF THE OESOPHAGUS 
Squamous cell carcinoma of oesophagus is characterised by both extensive local 
growth and affinity towards lymph nodal metastases. (49) As oesophagus has no 
serosal layer there is very early direct invasion of the contiguous structures. 
The growth in the oesophagus can impinge or invade the recurrent laryngeal nerves, 
carotid arteries and trachea. 
 
If extra oesophageal extension occurs in the mediastinum, trachaeoesophageal or 
bronchoesophageal fistula can occur. 
 
The growth in the lower third of oesophagus can invade the aorta or pericardium 
causing mediastinitis, massive haemorrhage or empyema. 
 
 
The location of lymph node metastasis is influenced by the origin of the primary 
tumour. Metastatic lymph nodal disease is found in approximately 70%of patients at 
autopsy. 
 
Akiyama studied the pattern of lymphatic metastases in patient with      oesophageal 
cancer who had had underwent surgical resection.  
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He found that in upper oesophageal cancer metastasis in neck lymph nodes was 
44.1%, upper mediastinum 50 %, middle mediastinum 20.6%, and lower 
mediastinum 5.9% with upper gastric area 14.7%.   
 
In mid oesophageal carcinoma metastasis in neck lymph nodes was 32.9%, upper 
mediastinum 38.1 %, middle mediastinum 41%, and lower mediastinum 20.2% with 
upper gastric area 42.5%. 
 
The involvement of abdominal nodes increases as ones disease involves more 
distally in oesophagus to the gastroesophageal junction 
 
For T1 lesions incidence of nodal spread is 14% to 21% and for T2 lesions incidence 
of nodal spread is 38% to 60 %.( 50) 
 
For patient with lower oesophageal and gastroesophageal junction adenocarcinoma, 
approximately 70% will have nodal metastasis at presentation. The involvement of 
both mediastinal and abdominal lymph nodes is common.  The involvement of 
abdominal nodes increases as ones disease involves more distally in oesophagus to 
the gastroesophageal junction. 
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CLINICAL PRESENTATION 
 The region of the primary tumour in the oesophagus may influence the presenting 
symptoms in patients. 
 
Dysphagia is most commonly seen in more than 90% of patient regardless of 
location. 
 
Odynophagia is a complaint in 50% of patients. 
Weight loss is also common in 40% to 70% of patients and the extent of weight loss 
is associated with worse prognosis. 
 
Less frequent symptoms of this condition are hoarseness, cough and 
glossopharyngeal neuralgia. 
 
In advanced lesions the signs and symptoms of tumour invasion into local structures 
predominates. These symptoms include hematemesis, haemoptysis, melena, 
dyspnoea and persistent cough secondary to tracheobronchial or 
bronchoesophageal fistula. 
The compression or invasion of the left recurrent laryngeal nerve or phrenic nerve 
can cause dysphonia or hemi diaphragm palsy. 
 
Other symptoms of Superior Vena Cava syndrome and   Horner’s syndrome can 
also occur. 
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Pleural effusion and exsanguinations due to aortic communication is also seen. 
Abdominal and back ache can occur in patient with celiac node involvement by the 
lower oesophageal growth. 
 
PROGNOSTIC FACTORS  
Stage of the oesophageal carcinoma at presentation is the most important 
prognostic factor in determining survival of the patient. The increase in depth of 
tumour penetration (i.e. T stage), lymph node involvement (i.e. N stage) and 
absence or presence of metastasis influences the outcome. Usually the patients with 
distant metastasis are rarely curable. The presence of lymphatic invasion suggests 
advanced stage and worse long term survival for the patient. (51) 
 
The site of tumour is reported to influence the survival. The patients with lower third 
experience improved outcome versus patient with lesion in the upper third of the 
oesophagus. (52) 
 
Tumour size also influences its outcome. According to a study the 2 year survival 
rate was 19.2% for patient with tumour <5cm in size versus 1.9% for patient with 
tumour >9cm. (52) 
 
Progression of tumour size is related with unresectability and more chances of 
distant metastasis. 
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The histological type of tumour is regarded as an independent prognostic factor in 
patient undergoing surgery. Siewert et al (53) had analysed 1000 patients with 
carcinoma oesophagus who had surgical resection done and on follow up found that 
5 year survival rate was 47% for patient with adenocarcinoma and 37% for 
squamous cell carcinoma. (53) 
 
It is also found that women tend to fare better than men with regard to survival. (52) 
 
It is suggested that Race may be a factor influencing survival. A study by Hussey 
reported higher survival rate in Caucasians than Afro American (52) In contrast to a 
recent study done in patient who were treated with radiation therapy and 
chemotherapy there was no statistical difference found between the races.  (54) 
 
 
Age is also been considered to be significant and it is shown that patient older than 
65 years age faring less well. (15) 
 
The extent of weight loss and patient’s low overall performance status also indicate 
poor prognosis in the disease. (52) 
 
 
The presence of deep ulceration of the lesion, sinus tract formation and fistula 
formation are other poor prognostic factors which also suggest local invasion. 
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At surgery the importance of obtaining uninvolved resection margins is of 
significance with regards to the long term outcomes in patient. An Intergroup study of 
patients who had chemotherapy preceding and following R1,R2 resection and 
patient not undergoing resection showed a similar outcomes but only patient who 
had R0 showed a substantial long term disease free survival. (55) 
 
 
In an observation by patterns of care survey done to evaluate the survival outcome 
of treatment in patients with squamous cell cancer and adenocarcinoma of the 
oesophagus between 1996 and 99.  
 
The multivariate analysis showed a considerable improvement in the survival of 
patients are being treated in centres with >500 new cancer patient per year as 
compared with centres who have <500. (56) 
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TNM staging of 0esophageal squamous cell cancer (SCC) 
(2010 Edition) 
 
 
The latest TNM staging system used is the American Joint Committee on Cancer 
(AJCC) and the International Union against Cancer (UICC) 2010 edition for the 
oesophageal cancer. As a result of analysis of worldwide data from patient with 
oesophageal cancer there have been changes between the 2002 and the latest 2010 
edition. 
 
The major changes which are present in the 2012 edition are- 
(1) There is separate staging group for squamous cell carcinoma and 
adenocarcinoma of oesophagus. 
 
(2) The tumours present at the oesophagogastric junction and proximal 5 cm of 
the stomach extending into the GE junction or oesophagus are now staged 
as oesophageal cancers. 
 
 
(3) The tumours with an epicentre in the stomach >5 cm from the GE junction, 
or those within 5 cm of the GE junction without extension into the 
oesophagus are classified as stomach cancers. 
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(4) The Tis is redefined as high grade dysplasia (HGD) which includes non 
invasive neoplasias. The term “carcinoma in situ” is no longer used. 
 
 
(5) T4 disease is subclassified based upon respectability of invaded adjacent 
structures/organ. 
 
(6) Nodal status is subclassified as per the number of regional nodes with 
metastases. 
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TNM staging of 0esophageal squamous cell cancer (SCC) 
 
 Table 1 –(Staging of Oesophageal carcinoma) Adapted from AJCC 
Cancer Staging Manual, Seventh Edition (2010))(57) 
Primary tumour (T)*  
TX Primary tumour cannot be assessed 
T0 No evidence of primary tumour 
Tis High-grade dysplasia• 
T1  Tumour invades lamina propria, muscularis mucosa, or submucosa  
T1a  Tumour invades lamina propria or muscularis mucosa  
T1b  Tumour invades submucosa  
T2  Tumour invades muscularis propria  
T3  Tumour invades adventitia  
T4  Tumour invades adjacent structures  
T4a  Resectable tumour invading pleura, pericardium, or diaphragm  
T4b  Unresectable tumour invading other adjacent structures, such as aorta, vertebral body, trachea, etc.  
Regional lymph nodes (N)∆  
NX  Regional lymph node(s) cannot be assessed  
N0  No regional lymph node metastasis  
N1  Metastasis in 1-2 regional lymph nodes  
N2  Metastasis in 3-6 regional lymph nodes  
N3  Metastasis in seven or more regional lymph nodes  
Distant metastasis (M)  
M0  No distant metastasis  
M1  Distant metastasis  
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Histologic grade (G)  
GX  Grade cannot be assessed - stage grouping as G1  
G1  Well differentiated  
G2  Moderately differentiated  
G3  Poorly differentiated  
G4  Undifferentiated - stage grouping as G3 squamous  
Anatomic stage/prognostic groups  
Squamous cell carcinoma◊  
Stage  T  N  M  Grade  Tumour location §  
0 Tis  N0 M0 1, X Any 
IA T1 N0 M0 1, X Any 
IB  T1 N0 M0 2-3 Any 
T2-3 N0 M0 1, X Lower, X 
IIA  T2-3 N0 M0 1, X Upper, middle 
T2-3 N0 M0 2-3 Lower, X 
IIB  T2-3 N0 M0 2-3 Upper, middle 
T1-2 N1 M0 Any Any 
IIIA  T1-2 N2 M0 Any Any 
T3 N1 M0 Any Any 
T4a N0 M0 Any Any 
IIIB T3 N2 M0 Any Any 
IIIC  T4a N1-2 M0 Any Any 
T4b Any M0 Any Any 
Any N3 M0 Any Any 
IV Any Any M1 Any Any 
 
Note: cTNM is the clinical classification,  
          pTNM is the pathologic classification.  
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                                    HUMAN PAPILLOMA VIRUS  
           Human papilloma viruses (HPV) are small, double stranded, non-enveloped 
DNA viruses that belong to family Papillomaviridae. They have icosahedral capsid 
made up of 72 capsomeres (figure 5) the double stranded supercoiled DNA 
contains about 3000 basepairs (bp).  
The DNA encodes for early genes E1 to E8 and late genomes L1 and L2. E6 and 
E7 early genes are implicated in oesophageal carcinogenesis.  
          More than 100 different HPV types are described associated with infection of 
anogenital tract and other sites. HPV infections (HPV 16, HPV 18) are most 
commonly transmitted by sexual contact. (59) 
 Figure 5 - Human papilloma virus, under electron microscope 
             
                               (Figure 5 Adapted from National Institutes of Health) 
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Papilloma virus does not have oncogenic potential but subsets of papilloma virus 
are clearly implicated in carcinogenesis in humans. (60) 
 
The evidence to suggest HPV association with human malignant diseases came 
first from the observations on epidermodysplasia verruciformis. This disease causes 
susceptibility to HPV types 5 and 8 which produces multiple flat warts. In one third 
of these patients squamous cell carcinoma of these warty lesions develops. (61) 
 
HPV associated with malignancy of both genital tract and non-genital tract have 
been divided as – 
 
 High Risk types (HPV 16, 18, 31, 35, 39, 45, 51, 52, 56, 59, 66, 68, 69, 73 and 82). 
 
 Low-Risk types (HPV 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, and 81)  
These are associated with benign lesions such as genital and skin warts. 
 
The different high risk HPV types have tendency to infect a specific sites of the 
human body according to their “tropism”.  
      They show 2 types of tropism - 
(a) Tropism for epithelial cell: these HPV types have preference towards 
cutaneous epithelium and cause infections as common warts, plantar warts 
and butcher's warts in skin. 
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(b) Tropism for mucous membranes: these HPV types have preference for 
mucous membrane and they cause infection of penis, scrotum, perineum, 
perianal region, vaginal introitus, vulva, and cervix. 
          As per the worldwide data in 2002, HPV is attributed in 5.2% of new cases 
(about 561,200 cases) involving cancer of cervix, anus, vagina/vulva, penis, 
mouth and throat. It is also the most commonly associated infectious agent in 
84% of new cervical cancer.           
Table 2 - Worldwide incidence and distribution of cancers attributed to high risk HPV
                                   
.                          (Table 2 Adapted from Global cancer statistics, 2002,) (58) 
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           MECHANISM OF VIRUS REPLICATION AND ONCOGENICITY  
The mode of exposure of oesophageal mucosa to the HPV is not known. There are 
several theories to suggest the probable HPV transmission. 
 
One theory suggests that increase in practise of oral sex could cause the HPV 
transmission. The similar mode is also ascribed to the HPV related oropharyngeal 
cancer. 
 
Some report postulate that intrapartum transmission during passage of baby 
through the HPV infected mothers can lead to the HPV transmission. But the real 
mode of transmission is not known. 
 
Usually the Papilloma virus gains entry through wounds or abrasions at the site. 
The virions then bind to heparan and cell surface glycosaminoglycans on human 
keratinocytes.The entry in to cell is then by clathrin dependent, receptor mediated 
endocytosis. Following which the disassembly of the viral capsid occurs and viral 
genome is exposed inside the endosome. 
 
For oncogenesis a part of viral genome is integrated to the host cellular genome. A 
break at E1 –E2 region during integration lead to interruption of E2 gene. The 
deletion of E2 gene leads to loss of control over E 6 and E 7 
early gene products of E6 and E7
                         Figure 6         THE GENOMIC STRUCTURE OF HPV 16 
E6 interaction with p53 accelerates 
suppressor gene and reduces its stability. E7 interacts with 
protein, to abolish cell cycle regulation.
pRB is  negative regulator 
transcription factors which prevent S
results with E2F replacement leading to 
replication. (60)(62) 
The inhibition of p53 and pRB 
which can further lead to malignancy. 
genes.  These
 formed are implicated in oncogenicity. 
proteolytic degradation of p53,
pRB, retinoblastoma 
   
of cell cycle and is related with the E2F family of 
-phase entry. The binding of E 7 with pRB 
production of proteins required for DNA 
by the viral E6 and E7 results in cell transformation 
 
32 
 HPV 
 
 
 
 a tumour 
33 
 
             HPV AND SQUAMOUS CELL OESOPHAGEAL CANCER 
 
          The first observations were made by Syrjanen et al. in 1982 by examining a 
series of 60 squamous cell carcinoma of oesophagus. He suggested a 
probable association of human papillomavirus (HPV) in aetiology of both 
benign and malignant squamous cell oesophageal lesions. (7)(63) 
 
            This morphological similarity found in the gross samples of squamous cell 
malignancy of oesophagus to the condylomatous lesions related to HPV 
infections led to further studies. (7)(62)(64)(65) 
 
 HPV are known to cause tonsil and oropharyngeal cancers. (62) (66) (67) 
(68) (69) (72) In view of contiguity of squamous epithelium of oropharynx 
with oesophageal epithelium the possibility that HPV could be involved in the 
pathogenesis of oesophageal malignancy could be a possibility. 
 
The evidence of HPV involvement in oesophageal malignancy is supported 
by various reasons. 
 
 
(1)  Evidence of HPV involvement in benign squamous cell papilloma of 
oesophagus.  
HPV types 16 and 18 are frequently isolated from such papilloma. (62) It is a 
rare condition and so study with large numbers is not present. There are 
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about 239 reported cases of oesophageal squamous cell papilloma in 
literature which have detected HPV in 21.3% (n=51) of cases. (67) (70) 
 
(2)  HPV detected in oesophageal precancer sites.  
Oesophageal squamous malignancy progresses through the distinct 
precursor lesions as dysplasia and carcinoma in situ leading to cancer. HPV 
was detected in such lesions. (71)(70) 
 
(3)  Evidence of HPV in animal studies. 
 The studies on cattle experimentally demonstrated papillomatosis and 
malignant transformation to carcinoma following infection of bovine 
papillomavirus type 4 (BPV-4). BPV - 4 DNA is also frequently isolated from 
naturally or experimentally occurring papillomas in cattles. (73)(74)  
It is also found that bracken fern consumed by cattle act as a co factor in 
BPV induced carcinogenesis. (73) 
 
(4)  In vitro studies:   
The cultured oesophageal epithelial cells in vitro incubated with HPV showed 
malignant transformation. The study provides a model to demonstrate the 
association between HPV and etiopathogenesis of oesophageal malignancy. 
(75)(76) 
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(5) Seroepidemiological evidence: 
The presence of antibodies to virus like particles(VLP) specific to HPV in 
patients with squamous cell carcinoma of oesophagus HPV infection as a 
risk factor for this disease. In Shaanxi Province, China studies have shown 
24% of patients and 7% of control were seropositive. 
          However the role of HPV in squamous cell carcinoma of oesophagus is still 
controversial. The arguments against the possible association include: 
(a) Huge variation in HPV prevalence in the present available literature case series 
ranging from 0 to 100%.  
(b)  Inconsistent associations between HPV exposure (as measured by serology) 
and squamous cell carcinoma of oesophagus. 
(c) Contamination of sample during collection, procession and testing can lead to 
false positive results as HPV is known to cause other common epithelial lesions 
in humans. 
 A recent  meta analysis of 152 studies which covered a total of  10,234 ESCC 
cases,  analysed by different HPV detection methods in different geographic regions  
concluded that wide variability in HPV detection rates in ESCC is not due to the 
HPV detection techniques, but by the geographic origin of the study.(14)  
 
These data substantiate the recently elaborated concept that ESCC might have a 
different etiology in low-incidence and high-incidence geographic regions, HPV 
playing an important role only in high incidence areas. 
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DIFFERENT METHODS USED IN DETECTION OF HPV IN 
OESOPHAGEAL CARCINOMAS 
Various methods are used to detect HPV in the sample of oesophageal carcinomas. 
From late 1980 different techniques were used and now most have been replaced by 
the latest technique. 
FILTER IN SITU HYBRIDISATION 
This technique was used widely in late 1980. It was routinely used to detect HPV 
DNA from mucosal samples of the genital tract. The technique had low sensitivity 
and poor specificity. In early 1990 the technique became obsolete. 
This technique had resulted in considerable higher positivity for HPV DNA than other 
technique because of its high false positivity rate. 
IN SITU HYBRIDISATION 
It is one of the most frequent techniques used in various studies. Different studies 
including about 1485 cases of oesophageal squamous cell carcinoma ISH was used. 
The HPV 16 was most frequently detected serotype. It showed HPV DNA in 22.9% 
of cases with oesophageal cancer. 
POLYMERASE CHAIN REACTIONThis is the latest and most sensitive technique 
used to detect HPV DNA in oesophageal carcinoma. The overall detection rate of 
HPV as compared to other technique is low. The higher rate of positive result in 
other hybridisation technique would be due to the cross hybridisation of probe DNA 
to the human DNA. The detection rate of PCR in different studies with 1183 cases of 
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squamous cell carcinoma of oesophagus was 15.6 %. In our study PCR was used to 
detect the presence of HPV in the sample tissue. 
                   TECHNIQUE OF POLYMERASE CHAIN REACTION 
This technique was first published in 1985 by Kary B. Mullis who received the Nobel 
Prize in chemistry for inventing this technique. 
Today PCR is the basis of modern molecular genetics and molecular biology. It 
causes fast, highly specific amplification of the DNA fragments. It is guided by two 
main principles – 
1) Complimentarity driven DNA formation of duplex. 
2) Template driven DNA synthesis by DNA polymerases. 
 
The main process of PCR consists of the following three steps which are repeated 
for 30 to 40 times.  (Figure 8) 
 
STAGE 1 Denaturing:  The DNA double strands are denatured to form single strands 
by heating to 95 degrees. 
 
STAGE 2 Annealing: The mixture is cooled for binding of primer to the single 
stranded DNA following which the DNA polymerase binds to the 3’ end of the primer. 
 
STAGE 3 Elongation: The temperature is raised to 70 – 72 degrees which activates 
the polymerase to initiate chain elongation. The enzyme  polymerase act as catalyst 
for addition of nucleotides to the primers.  The cycle is maintained for 1 minute and 
then terminated by raising temperature to 95 degrees thus cycling back to stage 1. 
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                    Figure 7     Stages of a Polymerase chain reaction 
 
          When the process is completed the amplified product in placed for Gel 
electrophoresis. The negatively charged DNA fragments migrate towards the positive 
electrode and the speed of the fragment depend upon the size of the DNA. Then 
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ethidium bromide is added which stain the DNA as fluorescing band in UV light. The 
gel is photographed for further recording of the same. 
           HPV VACCINES AND HPV ASSOSIATED SQUAMOUS CELL 
CARCINOMA OF THE OESOPHAGUS           
              Human Papilloma Virus  are proven to cause over 70% of cervical cancer. 
The most common serotype which is associated with cervical cancer is HPV type 16 
and 18. There has been a major breakthrough following the introduction of HPV 
vaccines which target these high risk serotypes. 
            The vaccines Gardasil is a quadrivalent which also targets HPV serotype 6 
and 11 along with the serotype 16 and 18 
            The vaccine Cervarix is bivalent which specifically targets only the high risk 
serotype 16 and 18. 
            The vaccines in a randomised control trial has efficacy rate as high as 90-
100% in preventing cervical cancer for women who are HPV sero negative. 
           These vaccines are intended for prophylactic use and advised for only young 
girls. 
           A similar impact can also be expected in regions where there is substantial 
prove for HPV associated squamous cell carcinoma of the oesophagus. 
           At present still the etiological significance of HPV is debatable. In view of 
inconclusive data to support the role of HPV in oesophageal cancer it is not possible 
to suggest HPV vaccination for prevention of this disease. 
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          However in regions of China where there have been a significant high 
prevalence of oesophageal cancer even if HPV is associated with small proportion of 
cases, the vaccines can have significant impact.   
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PATIENT SELECTION AND METHODOLOGY 
 
The patients who presented to General Surgery Unit 3 and Department of 
Gastroenterology with oesophageal carcinoma were included in this study. Informed 
consent was obtained from the participants who were willing to participate in this 
study. Patient who were detected to have confirmed squamous cell carcinoma of the 
oesophagus of the oesophagus were included as case participants or Group A. 
These patients had biopsy of the lesion for routine histopathology and also for the 
study. A second biopsy of the surrounding normal mucosa not less than 5 cm from 
the edge of the lesion was also taken for analysis in this study. 
 
The control group (Group B) included patients undergoing upper GI endoscopy for 
dyspeptic symptoms. They were included to study to look at the prevalence of HPV 
virus in the non malignant population This group had biopsy from the normal mucosa 
of the middle third of oesophagus for  HPV DNA analysis.  
 
The biopsy samples  from both the groups which were collected and coded 
separately and then taken to the Clinical Virology laboratory for further analysis. 
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Eligibility criteria   
All cases with histopathology proven squamous cell carcinoma of the oesophagus.  
 
Exclusion criteria 
(i) Patient who had previous treatment or neoadjuvant therapy for carcinoma 
oesophagus. 
(ii) Immunocompromised states (HIV, Cirrhosis of liver, chronic renal failure, 
uncontrolled diabetes etc.) 
SAMPLE SIZE 
HPV infection shows a great variation in geographical distribution worldwide and also 
in India between different regions. A prospective observational case control study 
was designed. 
Assuming the proportion of HPV positive in case group                -       0 .40 
Assuming that proportion of HPV positive in control group            -       0.10 
Power of study (1-β)                                                                       -     80       
α Error %                                                                                         -      5                 
           No. of participants   required in “each group “                      =    38           
                                            TOTAL (case + control)                      =     76       
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The following variables were studied in the two groups i.e. Group A and Group B 
                     AGE 
                     GENDER 
                     REGION 
                     RESIDENT OF TOWN /VILLAGE 
                     EDUCATION 
                     SMOKING HABIT 
                      ALCOHOL 
                      DIET 
                     USE OF HOT BEVERAGES AS TEA/COFFEE 
                      OTHER COMORBIDITY 
                      ENDOSCOPY SITE OF LESION 
                      HISTOPATHOLOGICAL GRADE OF CARCINOMA 
                      PRESENCE OF HPV TYPE 16 & 18 AND OTHER TYPES 
                              
STASTISTICAL METHODS: 
The categorical variables in this study are described using frequency and 
percentage. Chi-square test was used to assess any association between these 
categorical variables and the results will be presented along with odds ratios and 
their respective confidence intervals.  Multivariable logistic regression was performed 
with candidate variables that were significantly associated with the outcome at 10% 
significance level and also with those that are clinically relevant. A p-value < 0.05 is 
to be considered statistically significant.                              
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METHODOLOGY 
Sample collection:  
● The coded biopsy tissue in viral transport medium was collected and 
transported in an ice container to the Clinical Virology laboratory. (Viral transport 
medium (VTM) is a balanced isotonic solution at physiological pH. It maintains the 
virus in the viable state. Generally contains foetal calf serum and wide spectrum 
antibiotic). 
 
● Once received, the sample was transferred to a 1.5ml eppendorf tube and 
stored at -800C until further testing. 
 
● The coded sample was processed through the following steps. 
 
 
DNA Extraction protocol: 
DNeasy® Tissue kit: (Qiagen GmbH, Hilden, Germany) 
Principle: Column based separation. 
● Tissue weighing 25mg and is digested by adding ATL buffer and Proteinase K 
at 56C. 
● Once digested, an equal amount of AL (Lysis buffer) buffer and Ethanol is 
added. 
● The DNA gets precipitated and its washed twice by adding buffers (AW1 and 
AW2) 
● The DNA is then eluted by adding elution buffer. 
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● The extract (containing the DNA) is stored at -20C until further testing. 
 
Polymerase Chain Reaction (PCR): 
● A known positive control is used for PCR and beta-globin serves as internal 
control. 
● Primers used: a) PGMY 09/11: Target size: 450 basepair. 
            b) PCO4/GH20 (Beta-globin): 230 basepair 
● A sample can be analyzed only if the beta globin is positive.  
● Based on the presence or absence of target band (450bp), the sample is 
interpreted as positive or negative. 
 
 
The PCR was carried out as a single step non-nested PCR. These universally used 
primers detect most of the oncogenic HPV types including HPV 16 and 18. Detection 
of the amplified products was carried out by electrophoresis in an ethidium bromide 
stained 2.5 % agarose gel. Presence of a 450 base pair HPV DNA specific product 
and a 230 base pair beta globin specific product indicates a positive result. 
PGMY09/11 is a set of consensus primers which has higher sensitivity, specificity 
and reproducibility (Gravitt, P. J. Clin. Microbiol. 38:357-361). 
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The cycling conditions in the PCR are 95oC, 10min followed by 40 cycles of 95oC, 
1min; 55oC, 1min and 72oC, 10min and a final elongation step of 72oC, 10min.  
 
Schematic depiction (figure 8) of different sets of primer utilized for HPV DNA 
detection studies. Usually the primers targeting L1 gene of HPV viruses are the most 
often used. 
Figure 8 Different sets of primer utilized for HPV DNA detection studies 
 
 
 
(Figure 8 adapted from Kleter B, J Clin Microbiol. 1999 Aug; 37(8):2508-17) 
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The thermal cyclers used for PCR are - 
a) Veriti TM Thermal Cycler (Applied Biosystem, Foster City, California, USA). 
b) GeneAmp® PCR system 9700 (Applied Biosystem, Foster City, California, 
USA). 
 
 
 
Sequencing of DNA: 
● If sample is positive for HPV, the amplified PCR products will be purified by 
Millipore filtration and sequenced directly using an ABI Prism Big Dye terminator 
cycle sequencing ready reaction kit. 
●  After a post-sequencing clean-up by Millipore filtration, the sequencing 
reactions will be run on an ABI PRISM 310 genetic analyzer (PE Applied 
Biosystems, CA, USA).  
● Finally, the data will be analyzed using Bioedit software version 7.0.5.3 and 
study sequences compared to the GenBank HPV sequence.                                  
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IMAGE SERIES TO DEPICT THE METHOD OF PROCESSING 
AND POLYMERASE CHAIN REACTION DONE FOR THE 
STUDY SAMPLES 
LEGENDS 
IMAGE 1     Viral transport media or VTM:   It is a balanced isotonic solution 
at physiological pH. It maintains the virus in the viable state. Generally 
contains fetal calf serum and antibiotics. 
IMAGE 2       Biosafety Cabinet (BSL-B2). 
 
IMAGE 3        Sample transfer to a 1.5ml eppendorf tube. 
 
IMAGE 4         Storage of sample at -80 degrees. 
 
IMAGE 5         Extraction of samples 
 
IMAGE 6         PCR process: Veriti TM Thermal Cycler (Applied Biosystem, 
Foster City,California, USA). 
 
IMAGE 7         GeneAmp® PCR system 9700 (Applied Biosystem, Foster 
City, California, USA).    Thermal cycler used for PCR. 
 
 
 
 
IMAGE 8       Gel- Doc : apparatus used for the gel electrophoresis of the 
amplified sample of the PCR process.
 
IMAGE 9      Sequencer (Applied Biosystem 310 Genetic Analyzer).
                             Electropherogram picture:
The below picture is just an example of how the readout is from the 
sequencing machine. 
 
IMAGE 10     Gel Electrophoresis 
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                                                         RESULTS 
The total number of case and control participants at the end of study was as follows. 
The total number of case participants with histologically proven squamous cell 
carcinoma of the oesophagus, who enrolled for the study, was 45. (GROUP A) 
The total number of control participants who enrolled for the study was 38. ( GROUP 
B). 
Thus total number of participants who were evaluated was 83.  
Figure 9.    Distribution of case (Group A) and control (GROUP B) patients in this 
study. 
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Figure 10:       Depicts the distribution of 
 
 
 
Most of case participants who had squamous cell carcinoma oesophagus enrolled in 
our study were more than 50 years
our study participants with total number of 37. This depicts that carcinoma of 
oesophagus which we see in our patients at our centre mostly occurs at age after 50 
years. 
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Figure 11.    Gender  distribution of   Case participants  / Group A who had 
squamous cell carcinoma of oesophagus 
 
                                                
 
 
MALE 66.7 % 
FEMALE 33.3 % 
 
The  gender profile of our study shows that the squamous cell carcinoma in our 
participants is present more in male gender i.e. twice as more  common . 
The similar findings are also found in literature which supports the male 
predominance pattern seen across the world. 
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Figure 12: Depicts the age distribution for control / group B 
 
 
 
 
The control /group B consist most of the individual in the age group of 21-50 years of 
age. The control group had patient endoscopy done for dyspeptic symptoms and did 
not suffer from carcinoma of oesophagus.                            
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Figure 13.     Depicts the Gender distribution of    GROUP B / Control participants 
 
 
 
 
MALE 60.5  % 
FEMALE 39.5  % 
 
The control participants who have enrolled for our study had male predominance 
with more than half the number comprising of male individual. 
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Table 3.  The distribution table of various state our case participants / Group A 
belong who come to our centre for treatment. 
 
  STATE  
TOTAL NUMBER 
 
TAMILNADU 
11 
WEST BENGAL 5 
JHARKHAND 3 
ASSAM 
13 
ANDHRA PRADESH 1 
ORISSA 0 
TRIPURA 1 
KERALA 2 
MIZORAM 
1 
BANGLADESH 2 
SIKKIM 1 
MEGHALAYA 
3 
CHATTISGARH 2 
Total 45 
 
Figure 14 Depicting percentage State of residence 
 
 The majority of participants enrolled were from the North east part of India 
predominantly the state of Assam. The second most common state of origin was 
Tamil Nadu, because of the geographical location of our centre.  
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Table 4.  State wise distribution of control / Group B population. 
STATE TOTAL NUMBER OF 
PATIENT IN CONTROL 
/ GROUP B 
TAMILNADU 9 
WEST BENGAL 18 
JHARKHAND 5 
ASSAM 2 
ANDHRA PRADESH 2 
ORISSA 1 
TRIPURA 1 
KERALA 0 
MIZORAM 0 
BANGLADESH 0 
SIKKIM 0 
MEGHALAYA 0 
CHATTISGARH 0 
 
Figure 15 Depicting percentage of state of residence. 
 
Most of the patient in control / Group B were from West Bengal. 
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 Figure 16.  Educational status
carcinoma oesophagus. 
 
 
          Table 5                      EDUCATION
 
ILLETERATE 
PRIMARY 
SECONDARY 
GRADUATE 
POST GRADUATE 
 
 
Most of the participants who have carcinoma of oesophagus have education level of primary 
class. The distribution depicts the pattern seen globally as suggested by literature
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Table   6. Depicts the place of residence of case participants/ Group A in study 
 
RESIDENTIAL AREA NUMBER OF CASE / GROUP A 
TOWN / URBAN 23 
VILLAGE / RURAL 22 
 
Figure 17 Depicting place of residence of Group A 
 
 
 
The case group participants were equally from both town and village. We did not 
found difference of residence in our study. 
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Figure 18.    Depicts the dietary habit of case participants / Group A 
 
 
 
Most participants with SCC of oesophagus had non vegetarian diet status. 
Only about 13.3 % of case participants had vegetarian diet. 
 
 
Table 7.  Depicts the smoking habit of Case participants / Group A 
 
 %  OF CASE / GROUP A 
NON SMOKER 48.9 
SMOKER 51.1 
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Figure 19 Depicting smoking habits of Group A 
 
Table 8 Depicting pack years of smokers in Group A 
       NUMBER OF PACK  YEARS 
NUMBER OF SMOKERS IN CASE /GROUP A                  .                                         
(n = 23) 
                            <  10 8 
                       > 10 15 
 
 
            There was no significant difference in smoking habit in patient who had 
squamous cell carcinoma of oesophagus. There was presence of similar proportion 
of smokers and non smoker in the cases as depicted above. Majority of smokers had 
smoked >10 pack years. 
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Figure 20.  Alcohol consumption pattern of Case participants/ Group A 
 
The proportion of people who consumed alcohol in case / group A was 51.1 %. 
 
Figure 21.  Regular consuming hot beverage in Case participants 
 
Table 9 Table showing percentage of patient consuming hot beverages in Group A 
CONSUMPTION OF HOT BEVERAGES %  OF CASE / GROUP  A 
NO 4.4 
YES 95.6 
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Figure 22: Depicts number of cups of coffee/tea consumed by Case participants who 
regularly take such hot beverages.
In case (Group A) who consume hot beverages majority of p
cups per day. 
 
Figure 23.  Depicts the distribution of positive
patients with oesophageal cancer. 
The presence of positive family history of carcinoma of oesophagus was seen in 
6.7% in case / Group A. 
Majority of Case i.e. 88.9% did not have family history of oesophageal carcinoma.
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Figure 24.  Depicts the predominant
with oesophageal carcinoma. 
 
 
Table 10 showing predominant symptoms of patients in Group A
 
PREDOMINANT SYMPTOM AT 
PRESENTATION 
DYSPHAGIA 
REFUX WITH DYSPEPSIA 
REFLUX WITH WEIGHT LOSS
RELUX WITH OTHER SYMPTOMS
 
 
Majority of our patients in case / Group A who had carcinoma of oesophagus 
presented with Dysphagia which was progressive in nature.
Dysphagia was seen in 84.4% of cases.
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Table 11. Depicts  the location of oesophageal lesion in participants with 
oesophageal carcinoma. 
 
 
LOCATION OF OESOPHAGEAL LESION FREQUENCY   (n) 
UPPER 10 
MIDDLE 25 
LOWER 10 
 
 
Figure 25 depicting location of oesophageal lesion in Group A 
 
 
 
 
 
 
Majority of case participants (i.e. 56%) who had carcinoma of oesophagus had lesion 
at the middle third of oesophagus. 
There was equal distribution in upper and lower part of the oesophagus. 
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Figure 26 Depicting grade of osephageal tumour
 
 
 
 
 
The majority of case / Group A (i.e. 
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Table 13.  Presence of HPV in case participants with SCC of oesophagus
 
Detection of any high risk HPV virus from the tumour lesion in 
cases                 
Detection of high risk HPV type 16 and 18 virus from the tumour 
lesion            
Detection of any high risk HPV virus from the adjacent normal 
tissue (CASES)   
Detection of high risk HPV type 16 and 18 virus from the adjacent
(CASES  
Detection of any high risk HPV virus from the Control participants
Detection of high risk HPV type 16 and 18 virus from Controls
 
Figure 27 Presence of HPV in case participants with SCC of oesophagus
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The detection study PCR did not detect any evidence of HPV 16 or HPV 18 in our 
case participants with histologically proven squamous cell carcinoma of the 
oesophagus. There was no presence of virus in the tumour tissue and also in the 
surrounding normal tissue near the lesion. 
The PCR also failed to detect any other type of HPV virus present in the tumour 
tissue and also in the surrounding normal tissue near the lesion. 
The PCR also did not show any presence of HPV 16, HPV 18 or any other serotype 
of HPV in control participants with normal oesophagus. 
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DISCUSSION 
 
 The first reports suggesting the involvement of human papillomavirus (HPV) in the 
development of both benign and malignant squamous cell tumours of the 
oesophagus was  in 1982 by  Syrjanen et al.  Since then there are debatable 
evidences for association of HPV in oesophageal cancer and the role is 
controversial. The detection rate of HPV in different studies is variable from 0% to 
60-70%. 
The squamous cell carcinogenesis of the oesophagus is complex multistep process 
and it is hypothesised to have multifactor aetiology and no single agent is identified 
to cause malignancy. In the past two decades HPV has gained the interest to be the 
most likely infectious viral agent leading to oesophageal cancer. 
Though till yet the etiological role of HPV in oesophageal cancer is not established 
and is controversial. It is suggested that infection with HPV may act as co-factor or 
can synergise the effect of other carcinogens thus leading to carcinogenesis. 
Therefore it influences the progression rather than the initiation of the disease. 
 
A large Meta analysis of studies done by K.J Syrjänen (14) from 152 studies from 
1954 – 2012 which included a total of 10,234 squamous oesophageal cancer 
patients, analysed by different HPV detection methods in different geographic 
regions.  
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The results of this analysis conclude that HPV infection plays an important role in 
the pathogenesis of squamous cell carcinoma of the oesophagus only in high 
prevalence areas. Therefore HPV infection may not have an important role in the 
pathogenesis of the malignancy in India, since our country is an area of low 
prevalence of the malignancy. These findings were in concurrence to an Indian 
study by S.Katiyar et.al. (5), which concluded that HPV may not play important role 
for oesophageal cancer in India. 
 
In accordance with the evidence in the literature, our study did not show association 
between the HPV and squamous cell carcinoma of oesophagus.  
However a study done in Kashmir by Showket Hussain et al. has found significant 
proportion of squamous cell carcinoma of oesophagus with HPV infection. (80) The 
study had 19% HPV positive oesophageal cancer.  
It is of interest to note that the valley of Kashmir is a high prevalence area in India 
and in our study group we did not have patients from this geographical area. 
Apart from this, the HPV negativity in this study could be explained by the following 
reasons. 
(1) Low HPV copies present in the tumour lesion in squamous cell carcinoma of 
oesophagus. The HPV infection of the oesophagus differs from the infection as 
seen in the cervix.  
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          It is shown in a study by real time PCR that HPV copies in carcinoma 
oesophagus specimen is less than two orders of magnitude as that found in cervical 
cancers.  
  
 Based on this observation it was tried that a PCR proven series of HPV 16 
positive cervical cancer specimens were diluted to 0.1-0.01HPV /cell similar to the 
average number of copy seen in oesophageal cancers. (78) Then sample were 
tested under PCR and it was found to be negative for HPV serotype. Thus it was 
suggested that low HPV copy can cause low detection of high risk HPV in 
oesophageal cancer. 
 
(2) “Hit and Run” mechanism of carcinogenesis by HPV in oesophagus could be 
also responsible for absence of any HPV serotype in cancer specimens as 
suggested by Tone Bjorge et al. (79). They suggested that unlike the cervical 
carcinoma where there is continued expression of transforming protein of virus E6 
and E7 for the growth of tumour in case of oesophageal cancer there is loss of viral 
DNA as the disease advances. This mechanism is evident in HPV associated 
Bovine lesions in cattles. (74) 
       By analogy BPV-4 causes alimentary papillomatosis in cattle which is 
usually a self limiting disease. But if cattle in fed upon Bracken fern which contains 
quercetin which is an immunosuppressant and a mutagen it is unable to clear BPV- 
 
 
  Thus the viral protein in presence of the mutagenic agent leads to tumour 
progression in cattles. The virus though is not found in the tumour lesions. 
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In our study we found that there was no HPV DNA detected in the adjacent 
normal tissue around the lesion. This therefore excludes the possibility of chronic 
presence or colonization of HPV   leading to malignancy. 
 In our study there was also absence of HPV serotypes in the control or Group 
B with normal oesophagus and also the adjacent normal mucosa from the patient 
with carcinoma oesophagus. Though we do not have data for the prevalence of 
HPV in oesophagus from general population and it will requires a larger study to 
evaluate this. 
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                                CONCLUSIONS 
 
 
1. This study did not find any high risk HPV serotypes in patients with squamous 
cell carcinoma of the oesophagus. This is in concurrence with the evidence 
existing in the literature regarding HPV in low prevalence areas. 
 
 
2. There exists geographical variation in the incidence of SCC oesophagus in 
India. However, in this study, HPV infection was not seen in patients from the 
different geographical areas within India,  
 
 
3. The study also suggests the absence of high risk serotype HPV in the 
oesophageal mucosa of the control group as well.  
 
 
4. There is a need of a larger multicentre study to substantiate the results of this 
study and to confirm or confidently rule out the association between HPV and 
oesophageal carcinoma in the Indian population.        
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                           LIMITATIONS 
 
1. The study has a possible selection bias with regards to the geographical area 
represented by the patients and control groups. For example although 
Kashmir is a high incidence area in India, this geographical area was not 
represented in the study. 
 
 
2. The patient and control groups were not age matched and also differed with 
regards to the geographical area of origin.  
 
 
3. The control group included patients with dyspeptic symptoms needing 
endoscopy. This may be a confounding factor as this group may not 
necessarily represent the general population. 
 
 
4. Although the study met the sample size requirement, a larger study is needed 
to evaluate any significant association.  
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